The certificate enables CPI to support its partners in a complete RNA therapeutics journey to accelerate medicines and vaccines for clinical trials.
The Golden Ticket programme is open to hydrogen and climate technology companies using green innovation to tackle the climate change crisis.
CPI will benefit from investment funding to help boost British production of sustainable batteries.
The centre will be funded by the UK Government, announced in the Autumn Statement 2023, to build resilience for future health emergencies.
CEAMS will support the development and commercialisation of advanced sustainable materials and bring investment to the Greater Manchester region.
What are the challenges facing MedTech companies in the UK? What action is needed to boost the market? All this is discussed in our latest reports.
The partnership between three universities, alongside CPI, will deliver two business support programmes to strengthen the region’s economy.
CPI Enterprises invests in Newcastle University spin-out Marrabio to produce alternatives to bioactive proteins to be used in medicine and food production.
The centre is the UK’s hub for developing RNA vaccines and therapies with the capacity to deliver 100m vaccine doses in case of future health emergencies.
Page 1 of 74
To find out more about how we can work together, please enter your details below.